During this dynamic presentation we will discuss utilization of diuretics across diverse practice settings. From intravenous to subcutaneous administration, we will analyze different strategies for safe and effective decongestion for patients with heart failure.

This presentation will include the following topics: summary of the disease state including pathophysiology, discussion of the laboratory and radiologic tests needed to fully evaluate condition, surgical criteria, surgical process and chronic management of condition. Case studies will also be presented.

Women veterans face unique challenges, including an increased risk of death by suicide. Often influenced by adverse childhood experiences (ACEs), exposure to trauma, and military experiences, women veterans are twice as likely to die by suicide than their civilian counterparts. These numbers have escalated since the pandemic. Advanced practice providers who adopt a comprehensive trauma-informed care approach addressing the specific needs of women veterans can decrease the risk of death by suicide and promote recovery and well-being.

General overview of sexual health considerations in special populations with a focus on individuals with intellectual and developmental disabilities (IDD). Topics include the history of sexual and reproductive care of individuals with IDD in the U.S., contraceptive considerations and methods for minimizing trauma during sexual history taking and exams.

This conference presentation explores the increasingly recognized link between nutrition and mental health. It highlights the need for psychiatric mental health nurse practitioners to possess the knowledge and skills to discuss dietary changes with their patients effectively. Despite nutrition being a fundamental aspect of nursing, many of us feel inadequately trained to address this subject. The presentation will delve into the emerging field of nutritional psychiatry, with a special emphasis on the Antidepressant Diet. It will also provide practical suggestions on how to motivate patients to modify their diet to enhance mood stability. Additionally, the session will offer resources for thorough understanding and implementation of these strategies.

This session will provide updates in the diagnosis and management of Pulmonary Hypertension (PH) based on current, evidence-based literature and guidelines. Topics will include the basics of PH evaluation and current state of patient centered treatment, highlighting the important role of the PH advanced practice provider.

This session will focus on a critical part of management of type 2 diabetes: initiating basal insulin. Delayed insulin therapy is often associated with prolonged hyperglycemia and subsequent poorer outcomes such as increased microvascular and macrovascular complications. Thus, learning to add basal insulin to the treatment regimen can assist clinicians with avoiding clinical inertia in diabetes care. Primary care is in an ideal position for leveraging the patient relationship to overcome barriers to insulin such as fear of hypoglycemia, injections, or weight gain.Guideline-based strategies for the initiation of basal insulin with emphasis on the use of longer-acting analog insulins and technology to monitor glycemic control will be illustrated with advanced case studies.

Tailored for nurse practitioners committed to enhancing mental health care for BIPOC (Black, Indigenous, and People of Color) populations by embracing culturally competent practices. The presentation will explore the specific challenges these patients encounter, such as systemic obstacles, the effects of racism and discrimination, and the crucial role of cultural sensitivity within therapeutic environments. Attendees will gain insights into the integration of traditional and modern healing methods and deepen their understanding of how social determinants affect mental health. The session aims to offer actionable strategies for creating more inclusive health care environments, improving communication skills, and establishing trust with BIPOC patients. By the conclusion of this talk, participants will be better prepared to deliver empathetic and culturally informed mental health care, thereby improving patient outcomes and advancing health equity.

The period of transition from a hospital setting to the community setting is often challenging for pediatric patients and families and represents a critical time during which caregivers need support. Due to gaps between in-patient care and access to specialist or primary care providers (PCPs) in the immediate post-discharge period, increased rates of medication errors, emergency department or urgent care use, and caregiver distress may occur. Readmission and increased care utilization are both financially costly and emotionally burdensome, and care disparities for hospitalized children are significantly associated with social disadvantage and marginalization. While evidence strongly supports the need for focused transition of care intervention, few such programs exist.

This presentation will explore several successful pediatric transition care models, as well as outline best practices and clinical pearls related to pediatric care transitions for the PCP. After attending, participants will 1) demonstrate increased knowledge of best practices related to pediatric care transition, 2) understand and describe effective and innovative models of care, and 3) be able to articulate their role in optimizing care transitions to improve pediatric health equity.

Mycoplasma genitalium (MG) is a bacterial infection of growing concern in sexual health. As nurse practitioners, understanding MG is crucial for effective patient care. MG is a sexually transmitted bacterium responsible for various urogenital infections. Its unique characteristics, such as antibiotic resistance and asymptomatic carriage, pose challenges for diagnosis and treatment. We'll delve into the prevalence of MG globally and its association with symptoms like urethritis, cervicitis, and pelvic inflammatory disease. We'll also explore the implications of asymptomatic MG infection, which often goes undetected but can lead to serious complications. The presentation will cover diagnostic methods, including nucleic acid amplification tests (NAATs), and the importance of accurate diagnosis in guiding treatment decisions. We'll discuss treatment options, antibiotic resistance patterns, and the role of patient education in preventing transmission and recurrence. As nurse practitioners, we play a vital role in MG prevention and management. We'll highlight key nursing interventions, such as sexual health counseling, partner notification, and adherence support. Patient education on safe sex practices and regular STI screening will also be emphasized. Understanding MG is essential in providing comprehensive sexual health care. Through education, vigilance, and collaboration with patients, we can mitigate the impact of MG and promote healthier outcomes.

After attending this presentation, attendees will be able to:

• Discuss different stress testing modality options.
• Discuss points to consider when choosing the optimal stress test modality.
• Evaluate patient presentation to determine appropriate stress test order.
• Discuss interpretation of stress test results findings.
• Apply knowledge in selecting CV tests utilizing brief case presentations.

This presentation will provide APP with evidence based recommendations on choosing the appropriate stress test. The presentation will highlight factors that determine which test to choose. The presentation will also focus on interpretation of results of stress test findings. Participants will then actively engage in brief case presentation to apply knowledge learned in the session.

This presentation will describe the latest advancements in obesity pharmacology. This session will provide an in-depth look at the current medications used to manage obesity, focusing on pharmacological principles, prescribing practices, and patient management strategies. Through the use of real-world case studies, participants will explore the practical applications of these treatments in various patient scenarios, from initial assessment to long-term follow-up. These case studies will illustrate common challenges and effective solutions, enhancing the clinician's ability to tailor obesity management plans to individual patient needs. By the end of this session, Nurse Practitioners will gain a robust understanding of how to integrate these treatments into their practice to improve patient outcomes effectively.

This workshop equips nurse practitioners (NPs) with core skills to enhance patient communication and empower better health outcomes.

We'll delve into the importance of building rapport and trust as the foundation for effective counseling. You'll learn essential attending skills like active listening and open-ended questioning to create a safe space for patient dialogue.

The workshop will explore techniques from motivational interviewing (MI), a collaborative approach that helps patients explore their own desires and motivations for change. This can be particularly valuable when addressing lifestyle modifications or adherence to treatment plans.

By mastering these essential counseling skills and incorporating MI strategies, NPs can build stronger relationships with patients, foster self-management, and ultimately, achieve better treatment outcomes.

Practitioners are often faced with pediatric patient complaints which may or may not be of cardiac origin. Common complaints such as chest pain, palpitations, fainting and murmurs are sometimes difficult to unravel. This presentation will help the practitioner to focus on the physical findings and specific laboratory testing to determine how to diagnosis common cardiac issues in the ambulatory setting and when to refer to the specialist.

Promoting sexual health and encouraging male screening for sexually transmitted infections (STIs) is a critical skill for all nurse practitioners (NP). NPs play a crucial role in advocating for and facilitating STI screening among male patients. STI screening guidelines for males, emphasizing the prevalence of STIs and their impact on individual and public health will be discussed. Many STIs present asymptomatically in males, making routine screening essential for early detection and treatment. Common barriers that may prevent males from seeking STI screening, such as stigma, misconceptions, and lack of awareness and understanding these barriers is key to developing effective strategies for promoting screening uptake. Practical strategies for NPs to promote STI screening among male patients including integrating screening discussions into routine healthcare visits, providing education on STIs and screening guidelines, and offering confidential and non-judgmental testing options at all visits will be addressed. Promoting STI screening for males is vital for preventing the spread of infections and improving individual health outcomes. By addressing barriers, engaging patients, and providing support, NPs can play a pivotal role in advancing sexual health and reducing STI transmission in our communities.

This presentation focuses on medical therapy for patients with acute decompensated heart failure. Will focus on GDMT and multi-agent initiation as well as additional classes of medications indicated for ADHF.

This presentation will focus on the management of the elderly patient with type 2 diabetes. Case-study format will be used and will include CGM monitoring, insulin dosing/education and polypharmacy.

Pediatric anxiety disorders (PAD) are one of the most common disorders in pediatric psychiatry. PADs are also a group of disorders that most frequently persist into adulthood. Accurate identification of PADs can prevent treatment resistance and suicidal behaviors. Participants of this presentation will improve their diagnostic acuity by increasing their understanding of common signs and symptoms of PAD along with the underlining neuroscience. Participant's own anxiety will be lessened as they learn best evidenced based practices to treat a common class of disorders into remission.

Toxicological emergencies are commonly encountered in emergency and acute care settings, presenting varying degrees of severity. Among pediatric patients, certain substances pose significant risks, where even a small dose can prove toxic or lethal. This presentation will review common pediatric ingestants, focusing on these 'single-dose killers', highlighting clinical manifestations, and management priorities to allow nurse practitioners to manage these patients more competently.

PCP NPs care for patients with difficulty treating hypertension. This presentation discusses the pharmacokinetics of hypertensive medications, the critical decisions in stacking multiple medications, and building trust relationships through simple explanations to improve adherence when multiple medications are used.

This session will go in-depth with three patients that are diabetic, however have very different presentations. Each case will identify the impetus behind hyperglycemia that is not your usual reasoning. A review of each patient will be given from initial assessment to exact diagnoses to final treatment plan. 

Psychedelics have demonstrated potential for the treatment of trauma and trauma-related disorders when combined with psychotherapy. Rooted in ancient practices, psychedelics have made a modern resurgence in mental health. This presentation will explore the history, mechanisms of action, current research findings, legislative challenges, and future directions of psychedelics for advanced practice nurses.

In this session, presenters will address the critical need for children and adolescents to receive evidence-based mental health screening, assessment, and effective, brief interventions in primary care practices. The SBIRT (Screening, Brief Intervention, & Referral to Treatment) SAMHSA model will be the basis of our presentation.  We will identify evidence-based screening questionnaires and demonstrate brief focused mental health assessment of children/ adolescents who present with anxiety, depression, trauma/ stress related symptoms. We will also identify evidence-based screening, assessment, and intervention with children/ teens with suicidal thoughts/ behaviors and/ or thoughts of harming others.  Access to specialty mental health services is difficult for many families.  The availability of psychiatric/ mental health providers is often limited and there are wait lists of months to begin treatment.  We have developed a toolkit of brief, evidence-based mental health interventions that can be delivered by nurse practitioners in busy health care settings – while awaiting specialty treatment.  We will present interventions with the best research evidence to support effectiveness (Level 1 Evidence) for anxiety, depression, trauma/ stress related symptoms and suicidal thoughts and behaviors.  We will share resources we use (handouts, worksheets, & information sheets for patients/ parents) in pediatric primary care practice.

This presentation will explore the pivotal role of nurse practitioners (NPs) in fostering inclusive lactation practices in primary care by addressing social determinants of health (SDH). NPs are uniquely positioned to recognize and mitigate the impact of SDH on breastfeeding outcomes. The presentation explores how NPs can tailor lactation support to diverse populations, acknowledging factors such as socioeconomic status, cultural beliefs, and access to healthcare. Strategies for culturally sensitive counseling, community engagement, and advocacy for supportive policies are discussed. By considering SDH in lactation care, NPs can empower all individuals to achieve their breastfeeding goals, promoting health equity and inclusivity.

As the older adult population continues to grow, we need to focus on the age-related changes that impact cardiovascular health including altered physiology and pharmacokinetics and dynamics of common medications. We will review clinical guidelines for the primary conditions that are seen in the older adult population including hypertension, cardiometabolic syndrome, aortic stenosis, heart failure and atrial fibrillation. Through interactive engagement we will discuss application to diverse practice settings.

In this presentation, we'll explore endocrine emergencies commonly encountered in acute and emergency care settings. Beyond diabetes, disorders affecting the pituitary, thyroid, and adrenal glands can be the primary reason patients seek care and often complicate acute illnesses or injuries. We will delve into the pathophysiology, clinical manifestations, and emergent management strategies for these endocrine conditions.

Men’s mental health is an important topic for nurse practitioners because men have distinctive epidemiological profiles and clinical presentations in behavioral health. As clinicians, we must be aware of these gender differences so that we can best serve diverse patient populations. In this presentation, four key issues relevant to men's mental health will be covered: suicide; depression; stigma; and engagement with health care services.

Over the past few years there has been an explosion of new biologic agents approved for use in children and adolescents. Pediatric autoimmune, inflammatory and hematologic diseases have integrated biologic agents into treatment. Nirsevimab use in infants will greatly decrease RSV hospitalizations and teplizumab delays the onset of Type I diabetes. This presentation will provide an overview of use of common biologic agents to treat children, including co-management when children taking biologics present to primary care or urgent care with illness.

Practice has significant potential to inform policy. Likewise, policy can notably impact practice. This presentation explores the intersection of practice and policy on women's and gender-related health care across the lifespan. Selected examples related to NP practice, patient safety, and access to care will be discussed.

Description of the etiology, natural history, and treatment strategies for peripheral arterial disease. Sequalae of PAD including wounds, dependent rubor and rest pain will also be described with associated appropriate treatments. 

Type 2 diabetes by nature is often persistent and progressive, and many patients will eventually require insulin as beta cell function continues to deteriorate over time. Basal insulin is the first step after oral anti-diabetic drugs and other agents fail to get the patient’s a1c at goal. When Hgb A1c values and post-prandial glucose levels remain elevated despite higher basal insulin doses, the addition of mealtime insulin is indicted. There are a variety of ways to initiate prandial insulin, and these treatment regimens will be reviewed in this session. To facilitate the addition of prandial insulin, data from patient self-monitoring of glucose, carbohydrate intake, and patient activity will be incorporated in the plan of care. To further improve the accuracy of insulin treatment, the use of continuous glucose monitoring data will be integrated to demonstrate pattern management using several patient cases.

This presentation aims to empower Nurse Practitioners with knowledge and tools needed to navigate the gender affirming process of transgender youth. It also seeks to provide understanding on the gender affirming process for transgender youth encompassing legal, medical (including Health Care access), social including instances of discrimination and societal biases) and support network and resources.

This presentation will provide an evidenced based (EB), clinically-practical overview of contemporaneous evaluation and management of infants and children who present in the primary care setting with fever, in particular, fever without a clear source. Age-related protocols and recommendations for evaluation and management of febrile infants, children and adolescents seen in the primary setting will be discussed. Current EB pediatric fever guidelines will be comprehensively addressed. An overview of commonly utilized diagnostic tests in pediatric septic work-ups will be provided. Illustrative pediatric sepsis case studies will be integrated into presentation content.

As nurse practitioners, we understand the importance of taking a complete sexual health history of an individual at various stages of their life. This helps us to identify their health needs and provide appropriate care. However, sometimes these conversations can feel awkward, rushed, or unprepared for the responses that may be given. Initially, obtaining an accurate and meaningful sexual history may be difficult, but by learning the necessary techniques, this uncomfortable process can become a relaxed and productive interview. In this session, we will explore strategies for obtaining an accurate sexual history through interactive case studies covering genders across the lifespan.

This session will focus on the use of inotrope medications in heart failure across the spectrum. From therapy usage in cardiogenic shock, acute decompensated heart failure, bridge to LAVD or heart transplant, and ambulatory therapy for palliation.

This presentation will include a summary of pathophysiology of SGLT2 Inhibitors and current indications in treatment of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.

Schizophrenia affects an estimated 3.2 million people in the United States and most NPs see patients with this disorder in their practices. Learn about emerging pharmacological treatments for schizophrenia and strategies to optimize adherence to plan of care.

This session will review the epidemiology of youth suicide and help build knowledge and skills in key components of evidence-based suicide prevention including screening, safety planning, and reducing access to the most common means of youth suicide. Participants will also gain a greater knowledge of practices that foster resilience in children and adolescents and will be better prepared to address health equity and social determinants of health issues that contribute to youth suicide. Whatever their role, or clinical setting, participants will gain skills and confidence to help address the preventable tragedy of youth suicide.

This presentation examines the physiological changes and contraceptive needs of individuals during the postpartum period, including the impact of breastfeeding, hormonal fluctuations, and fertility return. Understanding these dynamics is essential for tailoring contraceptive counseling and options to individual preferences and circumstances. In this session, we will explore the different contraceptive methods available for postpartum individuals, ranging from immediate postpartum options such as intrauterine devices and implants to other methods such as oral contraceptives, pills, patch, ring, and non-hormonal methods. Each method's efficacy, safety, medical eligibility criteria, and implications for lactation are discussed, equipping providers with the knowledge to guide informed decision-making.

During this engaging presentation we will cover the key takeway points from the most recent atrial fibrillation guidelines. Case based discussions will highlight new nomenclature and evidence based treatment strategies.

Explained what are pituitary tumors and its management from the Endocrine point of view

This presentation will evaluate the relevance of pharmacogenetics to mental health treatments and outcomes. Participants will be able to describe the application of pharmacogenetics to the use of psychiatric medications, treatment outcomes, and practical clinical applications.

This presentation explores the latest trends and developments in maternal and reproductive health, focusing on key issues that impact the well-being of women and birthing people worldwide. The session will cover a range of topics including access to Health Care services, maternal mortality rates, family planning initiatives, advancements in reproductive technologies, and policies affecting women's health.

Attendees will gain insights into the challenges facing maternal and reproductive health today, as well as innovative solutions and best practices being implemented to address these issues. The presentation will also highlight the importance of education, empowerment, and advocacy in improving maternal and reproductive health outcomes for diverse populations.

Rheumatic Heart Disease remains endemic is low-resource countries, especially Asia, Africa, India, and Oceania with more than 300,000 pediatric deaths per year. The complexities of the Streptococcus pyogenes bacteria increase the autoimmune response and decrease the ease of vaccination development. This presentation describes the pathology, potential vaccination, the importance of clinical diagnosis for Strep infections and the need for antibiotic protocols for all countries.

Management of Osteoporosis. Management of Testosterone in males

This presentation will cover the newest psychopharmacology medications on the market for the treatment of ADHD. We will discuss the mechanism of action behind the agents, what the evidence shows concerning efficacy and potential side effects, and clinical pearls for prescribing for ADHD symptoms across the lifespan.

This presentation delves into the various pharmacological interventions available for the treatment of vaginitis, a common condition affecting women globally. Attendees will gain insights into the different types of vaginitis, such as bacterial vaginosis, candidiasis, and trichomoniasis, and the specific pharmacological treatments recommended for each. The session will also cover emerging trends, challenges in treatment, and best practices in managing vaginitis using pharmacotherapy. Participants can expect to deepen their understanding of how medications play a crucial role in alleviating symptoms and promoting recovery in patients with vaginitis.

This presentation focuses on the diagnosis of cardiac amyloidosis, a condition marked by the abnormal accumulation of amyloid proteins in the heart, which can lead to cardiac dysfunction. We will discuss the latest diagnostic techniques that aid in early detection, including advanced imaging technologies and biomarkers. Emphasizing a multidisciplinary approach, the session integrates new research insights to enhance patient care. Attendees will gain a comprehensive understanding of the complexities involved in diagnosing cardiac amyloidosis, empowering them to identify the condition more effectively in clinical settings.

There are key differences in the management of children with Type 2 diabetes compared to adults. Children’s unique medical needs are not just solely based on size differences. The age and developmental needs coupled with family dynamics and ever emerging treatments increases the intracity of caring for children and adolescents with diabetes. These components create challenges when these children present to the primary care office. The purpose of this presentation is to provide a better understanding of these unique differences by exploring updates in clinical practice guidelines and novel and emerging treatments for children diagnosed with Type 2 Diabetes.

Rates of depression in college students have increased dramatically in recent years. With many students seeking mental health care through a primary care provider, the goal of this presentation is to provide a holistic picture and guidance for this concerning trend. Up to date assessment and treatment recommendations will be presented, as well common comorbidities, which include anxiety, insomnia, and ADHD. 

Pediatric urgent care provides an after hours option for children and adolescents to get care if their primary care provider is not available. This presentation will cover evidence-based guidelines for prescribing for children and adolescents using a case studies of common and uncommon presentations in in the urgent care setting.

This presentation will focus on hormonal changes related to polycystic ovarian syndrome (PCOS), a common cause of gynecological issues in menstruating patients. Many patients with PCOS have increased risks for metabolic syndrome. Primary care providers caring for this population will learn how to recognize and diagnose PCOS and provide anticipatory guidance to reduce long term metabolic risks.

We will review the most current guidelines and indications. The emphasis will be on medications including newer medications. Learn about options to get patients to their goal, especially difficult to treat patients.

Impact of Covid-19 related illness and the pathophysiology of Diabetes, management and clinical outcomes.

The presentation will allow audience members to understand the underlying mechanisms of insomnia. Audience members will become familiar with a well validated sleep tracking tool that can be used in clinical practice. Audience members will also become familiar with behavioral strategies that can be used to support clients in managing insomnia.

Nurse practitioners have the potential to use procedural sedation to assist in diagnostic or therapeutic procedures. In pediatric patients, while this tool can be highly beneficial, it also carries inherent risks. This presentation will cover key aspects of procedural sedation, including indications, preparation, medications, recovery, and discharge criteria. With adequate knowledge and preparation, nurse practitioners can safely utilize procedural sedation and analgesia to facilitate patient care.

Men who engage in sexual activity with other men (MSM) are at a greater risk of contracting sexually transmitted infections, including HIV, compared to other groups. This emphasizes the need for effective prevention strategies. While using barriers such as condoms is highly effective in preventing these infections, some individuals perceive condoms as a hindrance to sexual pleasure or intimacy. Pre-exposure prophylaxis (PrEP) is now more accessible and available, which has been demonstrated to reduce the transmission of HIV. However, implementing PrEP requires a comprehensive understanding of safe sex practices within a sex-positive framework. In this session, we will discuss the available PrEP options, when to use them, and why it is essential to continue using condoms for sexual safety, using interactive case studies

This presentation will include case studies as we review case studies with patients who are statin intolerant, difficult to get to goal and familial hypercholesteremia. We review the most recent guidelines and incorporate newer dyslipidemia medications.

Autoimmune thyroid diseases (AITD) result from a dysregulation of the immune system leading to an immune attack on the thyroid. This presentation describes the clinical value of antibody testing for diagnosis and management of thyroid patients. Autoimmune thyroid diseases are usually accompanied by the presence of anti-thyroid peroxidase (TPO), anti-thyroglobulin (Tg), and thyroid-stimulating hormone receptor (TSHR) antibodies. The connection between TSH-receptor blocking and TSH-receptor stimulating antibodies in the management of thyroid disease will be examined. Guidelines from the American Thyroid Association and the American Association of Clinical Endocrinology for the treatment of autoimmune thyroid disease with be reviewed.

Legal issues dealing with mental health and guardianship by attorneys and the justice system.

The recommended immunization schedule for children and adolescents gets more complex every year, with the additions of new vaccines and changing recommendations for existing vaccines. Decreased vaccination rates has led to outbreaks of measles and other vaccine preventable diseases. This presentation will review the 2024 CDC/ACIP pediatric immunization recommendations and contraindications, including the addition of Nirsevimab the first monoclonal antibody.

Evidence-based, patient-centered contraception management has long been a mainstay of many nurse practitioners’ roles. This presentation will review important pharmacological underpinnings of contraception for nurse practitioners who manage patients during the reproductive life span. Historical aspects of contraceptive management along with updates regarding the current contraceptive landscape will be reviewed. We will also discuss approaches to help patients make informed decisions on choosing the best method that fits with their diverse needs.

Maximizing cardiovascular protection with GLP1-RA, effects of covid-19 to diabetes management, updates and trends in DM management.

This presentation with utilize a case study and open discussion approach to present evidence for the use of certain anti-hyperglycemic agents for the treatment of heart disease and other cardiovascular conditions.  

Eye Movement, Desensitization, and Reprocessing EMDR is an evidence-based therapy that should be considered in treating patients with a trauma history. Presentation will review training requirements, steps in the EMDR process as well as integration into practice.

Infants who are born prematurely can face a multitude of complications for the rest of their lives.  Neurodevelopmental disorders are the most commonly known, but these children can suffer from issues with their pulmonary, cardiovascular, and gastrointestinal systems. With early recognition and treatment, long term outcomes are improved.  It's important for providers who may be caring for patients that were born prematurely to have knowledge of these risks, how to identify the disorders and best treatment options.  Close monitoring, regular follow ups and early intervention will be crucial to ensuring a healthy childhood for these patients and their families. 

This presentation will focus on the differences of biological sex and gender presentation for common primary care health concerns. Focus will include pharmacological variations to recognize with prescribing medications, as well as hormonal and anatomical considerations with assessment and diagnosis.

Cardiovascular-Renal-Metabolic (CVRM) Diseases - also known as cardio-kidney-metabolic (CKM) syndrome - encompasses a constellation of conditions including cardiovascular disease (CVD), chronic kidney disease, and metabolic disorders such as diabetes and obesity which, combined, are the leading cause of death worldwide. This activity is designed to aid NPs who are pivotal members of the healthcare team to Understand the pathophysiologic interplay of cardiovascular-renal-metabolic diseases, Adopt guideline-driven strategies to mitigate risk and thoughtfully select therapies known to decrease the burden of disease across the CVRM spectrum, Recognize ways in which social determinants of health (SDOH) impacts barriers to optimal CVRM care and Identify ways in which new data and evidence-based approaches to comprehensive CVRM care may be swiftly integrated into individual practice.   

This presentation will focus on the most common challenges that practitioners encounter with initiating and adjusting insulin therapy in T2DM management and solutions to address these challenges. A case study approach will be utilized to demonstrate practical applications in the clinical setting.

Managing acutely agitated patients requires a balanced approach incorporating both non-pharmacologic and pharmacologic interventions. Non-pharmacologic strategies, including verbal de-escalation and behavioral techniques, serve as initial interventions to mitigate agitation. When non-pharmacologic measures prove insufficient, pharmacologic interventions become necessary adjuncts to safely manage the patient. By employing a comprehensive approach that utilizes both non-pharmacologic interventions and pharmacologic agents when warranted, nurse practitioners can more effectively manage acutely agitated patients, while assuring the safety of all individuals involved.

This presentation addresses the healthcare needs of newborns affected by maternal substance use disorder, congenital syphilis and ankylogossia. Maternal substance use disorder impacts newborn health and development along with the entire family unit. A national increase in syphilis and congenital syphilis cases underscores the importance of timely screening and treatment to prevent severe health consequences in mothers and their newborns. Ankyloglossia, or tongue tie, can impede breastfeeding and oral development, requiring early intervention for optimal outcomes. We will equip attendants with the latest best practices for these conditions while prioritizing early interventions to improve outcomes and promote health for newborns and their families. 

Ever since the WHI research results was released, there has been misinformation about hormone therapy. Come enjoy this presentation to address the evidence-based reality about hormone therapy and menopause.

Cardiometabolic disease is a group of common and preventable chronic diseases impacting the cardiovascular, renal, and metabolic systems. The prevalence of cardiometabolic disease has increased as the risk factors such as obesity, diabetes, and hypertension have increased. This presentation will give the attendee an opportunity to attend a session where we will define, deconstruct, and learn about the intersection of this disease process. I will break down diabetes mellitus, hypertension, lipid management, renal, and obesity to approach treatment of cardiometabolic disease. Application of case studies will be part of the session.

Clinical updates on new agents and technology for diabetes care.

Perinatal Mental Health: An overview of the assessment, diagnosis and treatment of perinatal mood and anxiety disorders with an emphasis on psychopharmacology options for treatment.

This course is designed for advanced practice providers who desire to enhance their clinical decision-making skills and expertise regarding pediatric differential diagnosis and patient management. Through a series of case study presentations, participants will engage in discussions to effectively identify, evaluate, and manage challenging presentations in pediatric patients.  Each case discussed will serve as a platform to focus on significant clinical pearls and common pitfalls including the interpretation of the history and physical examination, formulation of a differential diagnosis, and appropriate utilization of diagnostic tools and tests in pediatric patients. The complexity of caring for a pediatric patient focusing on subtle symptoms, identification of red flags, and the impact of developmental stages will be included.  In addition, this course will include a discussion of appropriate clinical guidelines and evidence-based management strategies to optimize patient outcomes.

Atherosclerotic Cardiovascular disease (ASCVD) is a leading cause of death for women worldwide. As dyslipidemia is a significant risk factor for ASCVD development, evidence-based dyslipidemia is paramount to holistic health and wellness for women across a variety of settings and age ranges. Managing pharmacotherapy of dyslipidemia for women often involves multiple nuances given the unique needs across the lifespan including pregnancy, breastfeeding, and the menopausal transition. Therefore, this presentation will review evidence-based strategies and patient-centered approaches to dyslipidemia pharmacotherapy as it relates to the unique needs of women across the lifespan.

This presentation addresses the pharmacological management of cardiac amyloidosis, highlighting treatments for both transthyretin (ATTR) and light-chain (AL) types. We will review targeted therapies such as TTR stabilizers and silencers for ATTR, and chemotherapy options for AL, discussing their mechanisms and clinical outcomes. Additionally, the session will cover essential symptom management strategies, including the use of diuretics and beta-blockers to alleviate heart failure symptoms common in amyloidosis patients. The presentation aims to provide a comprehensive overview of current and emerging treatments, emphasizing a multidisciplinary approach to enhancing patient care and outcomes in cardiac amyloidosis. This session is designed for Health Care professionals seeking to deepen their understanding of these complex therapeutic strategies and their practical applications in clinical settings.

Understanding what is thyroid disease and what are thyroid nodules and its corresponding management

Presentation of assessment and treatment protocols for patients with opioid use seeking MAT including children, perinatal care and using long acting options.

A review of the diagnosis and management of pediatric ARDS as set forth by the second Pediatric Acute Lung Injury Consensus Conference, as well as updates to the 2015 guidelines. A summary of the application of the PALICC-2 guidelines to clinical practice in an effort to reduce the significant morbidity and mortality associated with pediatric ARDS. 

Most providers are familiar with genital STI issues. But what happens when the STI is staring you back in your face? Come learn when STI are not in the genital region.